3Holman RC, Cures AT, Belay ED, et al. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics, 2003, 112:495-501.
4Shulman ST, Melish M, lnoue O, et al. Immunoglobulin allotypic markers in Kawasaki disease. J Pediatr,1993, 122: 84-86.
5Burns JC, Shimizu C, Shike H, et al. Candidate genes for susceptibility to Kawasaki Disease: analysis of preferentially transmitted alleles inpatient/parent triads. Pediatr Res, 2003,53:325A
6Leung DY, Meissner HC, Fulton DR, et al. Toxic shock syndrome toxin-secreting staphylococcus aureus in Kawasaki syndrome. Lancet, 1993,342: 1385-1388.
7Leung DY, Meissner HC, Shulman ST, et al. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease.J Pediatr, 2002,140:742 -746.
8Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med, 1991, 324: 1633-1639.
9Hirao J, Hibi S, Andoh T, et al. High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol, 1997,112: 152-156.
10Lin CY, Lin CC, Hwang B, et al. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr, 1992, 121 : 924-926.
